Article 4D.
160 words·~1 min read·
/nc/chapter-90/4dA research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Article 4D.
Prescription Drug Transparency.
§ 90-85.60. Definitions.
The following definitions apply in this Article:
(1)Interested parties. - All of the following:
a. State agencies that
(i)purchase prescription drugs or
(ii)employ prescribers.
b. Health insurance companies.
c. Health care service plan providers.
d. Pharmacy benefits managers.
(2)Manufacturer. - An entity or an agent of an entity that produces, prepares, propagates, compounds, processes, packages, repackages, or labels a brand-name or generic drug. "Manufacturer" does not include an entity engaged in the preparation and dispensing of a brand-name or generic drug pursuant to a prescription.
(3)Prescriber. - Any person authorized under the laws of this State to issue a prescription order.
(4)Prescription drug. - Defined in G.S. 90-85.3.
(5)Prescription order. - Defined in G.S. 90-85.3.
(6)Price. - The wholesale acquisition cost as defined in 42 U.S.C. § 1395w-3a(c)(6)(B).
(7)Secretary. - The Secretary of the Department of Health and Human Services. (2025-69, s. 8(a).)